Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Gonzalez-Martin, A; Alba, E; Ciruelos, E; Cortes, J; Llombart, A; Lluch, A; Andres, R; Alvarez, I; Aramenda, JM; de la Pena, FA; Barnadas, A; Batista, N; Calvo, L; Galve, E; Garcia-Palomo, A; Garcia-Saenz, JA; de la Haba, J; Lopez, R; Lopez-Vivanco, G; Martinez-Janez, N; de Duenas, EM; Plazaola, A; Rodriguez-Lescure, A; Ruiz, M; Sanchez-Rovira, P; Santaballa, A; Segui, MA; Tusquets, I; Zamora, P; Martin, M.

Nab-Paclitaxel in Metastatic Breast Cancer: Defining the Best Patient Profile

CURRENT CANCER DRUG TARGETS. 2016; 16(5): 415-428 Nº de citas: 11 [doi:10.2174/1568009615666150817121731]

Llovet, P; Sastre, J; Ortega, JS; Bando, I; Ferrer, M; Garcia-Alfonso, P; Donnay, O; Carrato, A; Jimenez, A; Aranda, E; Leon, A; Gravalos, C; Camara, JC; Feliu, J; Sanchiz, B; Caldes, T; Diaz-Rubio, E.

Prognostic Value of BRAF, PI3K, PTEN, EGFR Copy Number, Amphiregulin and Epiregulin Status in Patients with KRAS Codon 12 Wild-Type Metastatic Colorectal Cancer Receiving First-Line Chemotherapy with Anti-EGFR Therapy

MOLECULAR DIAGNOSIS & THERAPY. 2015; 19(6): 397-408 Nº de citas: 20 [doi:10.1007/s40291-015-0165-0]

Garcia-Alfonso, P; Ferrer, A; Gil, S; Duenas, R; Perez, MT; Molina, R; Capdevila, J; Safont, MJ; Castanon, C; Cano, JM; Lara, R.

Neoadjuvant and conversion treatment of patients with colorectal liver metastasis: the potential role of bevacizumab and other antiangiogenic agents

TARGETED ONCOLOGY. 2015; 10(4): 453-465 Nº de citas: 15 [doi:10.1007/s11523-015-0362-0]

Sole, CV; Calvo, FA; Lizarraga, S; Gonzalez-Bayon, L; Segundo, CGS; Desco, M; Garcia-Sabrido, JL.

Single-Institution Multidisciplinary Management of Locoregional Oligo-Recurrent Pelvic Malignancies: Long-Term Outcome Analysis

ANNALS OF SURGICAL ONCOLOGY. 2015; 22: 1247-1255 Nº de citas: 4 [doi:10.1245/s10434-015-4604-2]

Berrocal, A; Arance, A; Espinosa, E; Castano, AG; Cao, MG; Larriba, JLG; Martin, JAL; Marquez, I; Soria, A; Algarra, SM.

SEOM guidelines for the management of Malignant Melanoma 2015

CLINICAL & TRANSLATIONAL ONCOLOGY. 2015; 17(12): 1030-1035 Nº de citas: 6 [doi:10.1007/s12094-015-1450-4]

Aranda, E; Aparicio, J; Alonso, V; Garcia-Albeniz, X; Garcia-Alfonso, P; Salazar, R; Valladares, M; Vera, R; Vieitez, JM; Garcia-Carbonero, R.

SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer 2015

CLINICAL & TRANSLATIONAL ONCOLOGY. 2015; 17(12): 972-981 Nº de citas: 27 [doi:10.1007/s12094-015-1434-4]

Gavila, J; Lopez-Tarruella, S; Saura, C; Munoz, M; Oliveira, M; De la Cruz-Merino, L; Morales, S; Alvarez, I; Virizuela, JA; Martin, M.

SEOM clinical guidelines in metastatic breast cancer 2015

CLINICAL & TRANSLATIONAL ONCOLOGY. 2015; 17(12): 946-955 Nº de citas: 23 [doi:10.1007/s12094-015-1476-7]

Martin, M; Simon, AR; Borrego, MR; Ribelles, N; Rodriguez-Lescure, A; Munoz-Mateu, M; Gonzalez, S; Vila, MM; Barnadas, A; Ramos, M; Berron, SD; Jara, C; Calvo, L; Martinez-Janez, N; Fernandez, CM; Rodriguez, CA; de Duenas, EM; Andres, R; Plazaola, A; de la Haba-Rodriguez, J; Lopez-Vega, JM; Adrover, E; Ballesteros, AI; Santaballa, A; Sanchez-Rovira, P; Baena-Canada, JM; Casas, M; Camara, MD; Carrasco, EM; Lluch, A.

Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study

JOURNAL OF CLINICAL ONCOLOGY. 2015; 33(32): 3788 Nº de citas: 59 [doi:10.1200/JCO.2015.61.9510]

Sole, CV; Calvo, FA; Lizarraga, S; Gonzalez-Bayon, L; Garcia-Sabrido, JL.

Intraoperative electron-beam radiation therapy with or without external-beam radiotherapy in the management of paraaortic lymph-node oligometastases from gynecological malignancies

CLINICAL & TRANSLATIONAL ONCOLOGY. 2015; 17(11): 910-916 Nº de citas: 6 [doi:10.1007/s12094-015-1326-7]

Climent, MA; Leon-Mateos, L; del Alba, AG; Perez-Valderrama, B; Mendez-Vidal, MJ; Mellado, B; Arranz, JA; Sanchez-Hernandez, A; Cassinello, J; Olmos, D; Carles, J.

Updated recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with metastatic castration-resistant prostate cancer

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2015; 96(2): 308-318 Nº de citas: 14 [doi:10.1016/j.critrevonc.2015.05.019]

Trojan, J; Mineur, L; Tomasek, J; Rouleau, E; Fabian, P; de Maglio, G; Garcia-Alfonso, P; Aprile, G; Taylor, A; Kafatos, G; Downey, G; Terwey, JH; van Krieken, JH.

Panitumumab Use in Metastatic Colorectal Cancer and Patterns of KRAS Testing: Results from a Europe-Wide Physician Survey and Medical Records Review

PLoS One. 2015; 10(10): Nº de citas: 10 [doi:10.1371/journal.pone.0140717]

Noriega, V; Martinez-Laperche, C; Buces, E; Pion, M; Sanchez-Hernandez, N; Martin-Antonio, B; Guillem, V; Bosch-Vizcaya, A; Bento, L; Gonzalez-Rivera, M; Balsalobre, P; Kwon, M; Serrano, D; Gayoso, J; de la Camara, R; Brunet, S; Rojas-Contreras, R; Nieto, JB; Martinez, C; Gonzalez, M; Espigado, I; Vallejo, JC; Sampol, A; Jimenez-Velasco, A; Urbano-Ispizua, A; Solano, C; Gallardo, D; Diez-Martin, JL; Buno, I.

The Genotype of the Donor for the (GT)(n) Polymorphism in the Promoter/Enhancer of FOXP3 Is Associated with the Development of Severe Acute GVHD but Does Not Affect the GVL Effect after Myeloablative HLA-Identical Allogeneic Stem Cell Transplantation

PLoS One. 2015; 10(10): Nº de citas: 10 [doi:10.1371/journal.pone.0140454]

Escobar, Y; Cajaraville, G; Virizuela, JA; Alvarez, R; Munoz, A; Olariaga, O; Tames, MJ; Muros, B; Lecumberri, MJ; Feliu, J; Martinez, P; Adansa, JC; Martinez, MJ; Lopez, R; Blasco, A; Gascon, P; Calvo, V; Luna, P; Montalar, J; Del Barrio, P; Tornamira, MV.

Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study

SUPPORTIVE CARE IN CANCER. 2015; 23(9): 2833-2840 Nº de citas: 68 [doi:10.1007/s00520-015-2809-3]

Casla, S; Lopez-Tarruella, S; Jerez, Y; Marquez-Rodas, I; Galvao, DA; Newton, RU; Cubedo, R; Calvo, I; Sampedro, J; Barakat, R; Martin, M.

Supervised physical exercise improves VO2max, quality of life, and health in early stage breast cancer patients: a randomized controlled trial

BREAST CANCER RESEARCH AND TREATMENT. 2015; 153(2): 371-382 Nº de citas: 86 [doi:10.1007/s10549-015-3541-x]

Pereira, A; Mendizabal, E; de Leon, J; Perez-Medina, T; Magrina, JF; Magtibay, PM; Rodriguez-Tapia, A; Lizarraga, S; Ortiz-Quintana, L.

Peritoneal carcinomatosis: A malignant disease with an embryological origin?

SURGICAL ONCOLOGY-OXFORD. 2015; 24(3): 305-311 Nº de citas: 6 [doi:10.1016/j.suronc.2015.06.002]

Giuliano, M; Hu, HZ; Wang, YC; Fu, XY; Nardone, A; Herrera, S; Mao, SF; Contreras, A; Gutierrez, C; Wang, T; Hilsenbeck, SG; De Angelis, C; Wang, NJ; Heiser, LM; Gray, JW; Lopez-Tarruella, S; Pavlick, AC; Trivedi, MV; Chamness, GC; Chang, JC; Osborne, CK; Rimawi, MF; Schiff, R.

Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 Therapy

CLINICAL CANCER RESEARCH. 2015; 21(17): 3995-4003 Nº de citas: 101 [doi:10.1158/1078-0432.CCR-14-2728]

Carrato, A; Garcia, P; Lopez, R; Macarulla, T; Rivera, F; Sastre, J; Gostkorzewicz, J; Benedit, P; Perez-Alcantara, F.

Cost-utility analysis of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in combination with gemcitabine in metastatic pancreatic cancer in Spain: results of the PANCOSTABRAX study

EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH. 2015; 15(4): 579-589 Nº de citas: 12 [doi:10.1586/14737167.2015.1047349]

Cajal, TRY; Chirivella, I; Miranda, J; Teule, A; Izquierdo, A; Balmana, J; Sanchez-Heras, AB; Llort, G; Fisas, D; Lope, V; Hernandez-Agudo, E; Juan-Fita, MJ; Tena, I; Robles, L; Guillen-Ponce, C; Perez-Segura, P; Luque-Molina, MS; Hernando-Polo, S; Salinas, M; Brunet, J; Salas-Trejo, MD; Barnadas, A; Pollan, M.

Mammographic density and breast cancer in women from high risk families

BREAST CANCER RESEARCH. 2015; 17: Nº de citas: 20 [doi:10.1186/s13058-015-0604-1]